Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection
(1) Background: The detection of SARS-CoV-2 RNA in nasopharyngeal samples through real-time reverse transcription-polymerase chain reaction (RT-PCR) is considered the standard gold method for the diagnosis of SARS-CoV-2 infection. Antigen detection (AD) tests are more rapid, less laborious, and less...
Saved in:
Published in | Journal of clinical medicine Vol. 10; no. 2; p. 265 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
13.01.2021
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | (1) Background: The detection of SARS-CoV-2 RNA in nasopharyngeal samples through real-time reverse transcription-polymerase chain reaction (RT-PCR) is considered the standard gold method for the diagnosis of SARS-CoV-2 infection. Antigen detection (AD) tests are more rapid, less laborious, and less expensive alternatives but still require clinical validation. (2) Methods: This study compared the clinical performance of five AD tests, including four rapid AD (RAD) tests (biotical, Panbio, Healgen, and Roche) and one automated AD test (VITROS). For that purpose, 118 (62.8%) symptomatic patients and 70 (37.2%) asymptomatic subjects were tested, and results were compared to RT-PCR. (3) Results: The performance of the RAD tests was modest and allowed us to identify RT-PCR positive patients with higher viral loads. For Ct values ≤25, the sensitivity ranged from 93.1% (95% CI: 83.3–98.1%) to 96.6% (95% CI: 88.1–99.6%), meaning that some samples with high viral loads were missed. Considering the Ct value proposed by the CDC for contagiousness (i.e., Ct values ≤33) sensitivities ranged from 76.2% (95% CI: 65.4–85.1%) to 88.8% (95% CI: 79.7–94.7%) while the specificity ranged from 96.3% (95% CI: 90.8–99.0%) to 99.1% (95% CI: 95.0–100%). The VITROS automated assay showed a 100% (95% CI: 95.5–100%) sensitivity for Ct values ≤33, and had a specificity of 100% (95% CI: 96.6–100%); (4) Conclusions: Compared to RAD tests, the VITROS assay fully aligned with RT-PCR for Ct values up to 33, which might allow a faster, easier and cheaper identification of SARS-CoV-2 contagious patients. |
---|---|
AbstractList | (1) Background: The detection of SARS-CoV-2 RNA in nasopharyngeal samples through real-time reverse transcription-polymerase chain reaction (RT-PCR) is considered the standard gold method for the diagnosis of SARS-CoV-2 infection. Antigen detection (AD) tests are more rapid, less laborious, and less expensive alternatives but still require clinical validation. (2) Methods: This study compared the clinical performance of five AD tests, including four rapid AD (RAD) tests (biotical, Panbio, Healgen, and Roche) and one automated AD test (VITROS). For that purpose, 118 (62.8%) symptomatic patients and 70 (37.2%) asymptomatic subjects were tested, and results were compared to RT-PCR. (3) Results: The performance of the RAD tests was modest and allowed us to identify RT-PCR positive patients with higher viral loads. For Ct values ≤25, the sensitivity ranged from 93.1% (95% CI: 83.3–98.1%) to 96.6% (95% CI: 88.1–99.6%), meaning that some samples with high viral loads were missed. Considering the Ct value proposed by the CDC for contagiousness (i.e., Ct values ≤33) sensitivities ranged from 76.2% (95% CI: 65.4–85.1%) to 88.8% (95% CI: 79.7–94.7%) while the specificity ranged from 96.3% (95% CI: 90.8–99.0%) to 99.1% (95% CI: 95.0–100%). The VITROS automated assay showed a 100% (95% CI: 95.5–100%) sensitivity for Ct values ≤33, and had a specificity of 100% (95% CI: 96.6–100%); (4) Conclusions: Compared to RAD tests, the VITROS assay fully aligned with RT-PCR for Ct values up to 33, which might allow a faster, easier and cheaper identification of SARS-CoV-2 contagious patients. (1) Background: The detection of SARS-CoV-2 RNA in nasopharyngeal samples through real-time reverse transcription-polymerase chain reaction (RT-PCR) is considered the standard gold method for the diagnosis of SARS-CoV-2 infection. Antigen detection (AD) tests are more rapid, less laborious, and less expensive alternatives but still require clinical validation. (2) Methods: This study compared the clinical performance of five AD tests, including four rapid AD (RAD) tests (biotical, Panbio, Healgen, and Roche) and one automated AD test (VITROS). For that purpose, 118 (62.8%) symptomatic patients and 70 (37.2%) asymptomatic subjects were tested, and results were compared to RT-PCR. (3) Results: The performance of the RAD tests was modest and allowed us to identify RT-PCR positive patients with higher viral loads. For Ct values ≤25, the sensitivity ranged from 93.1% (95% CI: 83.3-98.1%) to 96.6% (95% CI: 88.1-99.6%), meaning that some samples with high viral loads were missed. Considering the Ct value proposed by the CDC for contagiousness (i.e., Ct values ≤33) sensitivities ranged from 76.2% (95% CI: 65.4-85.1%) to 88.8% (95% CI: 79.7-94.7%) while the specificity ranged from 96.3% (95% CI: 90.8-99.0%) to 99.1% (95% CI: 95.0-100%). The VITROS automated assay showed a 100% (95% CI: 95.5-100%) sensitivity for Ct values ≤33, and had a specificity of 100% (95% CI: 96.6-100%); (4) Conclusions: Compared to RAD tests, the VITROS assay fully aligned with RT-PCR for Ct values up to 33, which might allow a faster, easier and cheaper identification of SARS-CoV-2 contagious patients.(1) Background: The detection of SARS-CoV-2 RNA in nasopharyngeal samples through real-time reverse transcription-polymerase chain reaction (RT-PCR) is considered the standard gold method for the diagnosis of SARS-CoV-2 infection. Antigen detection (AD) tests are more rapid, less laborious, and less expensive alternatives but still require clinical validation. (2) Methods: This study compared the clinical performance of five AD tests, including four rapid AD (RAD) tests (biotical, Panbio, Healgen, and Roche) and one automated AD test (VITROS). For that purpose, 118 (62.8%) symptomatic patients and 70 (37.2%) asymptomatic subjects were tested, and results were compared to RT-PCR. (3) Results: The performance of the RAD tests was modest and allowed us to identify RT-PCR positive patients with higher viral loads. For Ct values ≤25, the sensitivity ranged from 93.1% (95% CI: 83.3-98.1%) to 96.6% (95% CI: 88.1-99.6%), meaning that some samples with high viral loads were missed. Considering the Ct value proposed by the CDC for contagiousness (i.e., Ct values ≤33) sensitivities ranged from 76.2% (95% CI: 65.4-85.1%) to 88.8% (95% CI: 79.7-94.7%) while the specificity ranged from 96.3% (95% CI: 90.8-99.0%) to 99.1% (95% CI: 95.0-100%). The VITROS automated assay showed a 100% (95% CI: 95.5-100%) sensitivity for Ct values ≤33, and had a specificity of 100% (95% CI: 96.6-100%); (4) Conclusions: Compared to RAD tests, the VITROS assay fully aligned with RT-PCR for Ct values up to 33, which might allow a faster, easier and cheaper identification of SARS-CoV-2 contagious patients. |
Author | Van Eeckhoudt, Sandrine Oliveira, Maxime Cadrobbi, Julie Douxfils, Jonathan Laffineur, Kim Morimont, Laure Dogné, Jean-Michel Elsen, Marc Favresse, Julien Nicolas, Jean-Baptiste Gillot, Constant Eucher, Christine Rosseels, Catherine |
AuthorAffiliation | 1 Department of Laboratory Medicine, Clinique St-Luc Bouge, 5004 Namur, Belgium; julie.cadrobbi@slbo.be (J.C.); marc.elsen@slbo.be (M.E.); christine.eucher@slbo.be (C.E.); kim.laffineur@slbo.be (K.L.); catherine.rosseels@slbo.be (C.R.) 2 Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, 5000 Namur, Belgium; constant.gillot@unamur.be (C.G.); maxime.oliveira@qualiblood.eu (M.O.); laure.morimont@unamur.be (L.M.); jean-michel.dogne@unamur.be (J.-M.D.); jonathan.douxfils@unamur.be (J.D.) 3 Department of Internal Medicine, Clinique St-Luc Bouge, 5004 Namur, Belgium; sandrine.vaneeckhoudt@slbo.be (S.V.E.); jeanbaptiste.nicolas@slbo.be (J.-B.N.) 4 Qualiblood S.A., 5000 Namur, Belgium |
AuthorAffiliation_xml | – name: 1 Department of Laboratory Medicine, Clinique St-Luc Bouge, 5004 Namur, Belgium; julie.cadrobbi@slbo.be (J.C.); marc.elsen@slbo.be (M.E.); christine.eucher@slbo.be (C.E.); kim.laffineur@slbo.be (K.L.); catherine.rosseels@slbo.be (C.R.) – name: 3 Department of Internal Medicine, Clinique St-Luc Bouge, 5004 Namur, Belgium; sandrine.vaneeckhoudt@slbo.be (S.V.E.); jeanbaptiste.nicolas@slbo.be (J.-B.N.) – name: 2 Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, 5000 Namur, Belgium; constant.gillot@unamur.be (C.G.); maxime.oliveira@qualiblood.eu (M.O.); laure.morimont@unamur.be (L.M.); jean-michel.dogne@unamur.be (J.-M.D.); jonathan.douxfils@unamur.be (J.D.) – name: 4 Qualiblood S.A., 5000 Namur, Belgium |
Author_xml | – sequence: 1 givenname: Julien surname: Favresse fullname: Favresse, Julien – sequence: 2 givenname: Constant orcidid: 0000-0002-4151-9760 surname: Gillot fullname: Gillot, Constant – sequence: 3 givenname: Maxime surname: Oliveira fullname: Oliveira, Maxime – sequence: 4 givenname: Julie surname: Cadrobbi fullname: Cadrobbi, Julie – sequence: 5 givenname: Marc surname: Elsen fullname: Elsen, Marc – sequence: 6 givenname: Christine surname: Eucher fullname: Eucher, Christine – sequence: 7 givenname: Kim surname: Laffineur fullname: Laffineur, Kim – sequence: 8 givenname: Catherine surname: Rosseels fullname: Rosseels, Catherine – sequence: 9 givenname: Sandrine surname: Van Eeckhoudt fullname: Van Eeckhoudt, Sandrine – sequence: 10 givenname: Jean-Baptiste surname: Nicolas fullname: Nicolas, Jean-Baptiste – sequence: 11 givenname: Laure surname: Morimont fullname: Morimont, Laure – sequence: 12 givenname: Jean-Michel surname: Dogné fullname: Dogné, Jean-Michel – sequence: 13 givenname: Jonathan orcidid: 0000-0002-7644-5298 surname: Douxfils fullname: Douxfils, Jonathan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33450853$$D View this record in MEDLINE/PubMed |
BookMark | eNptkUFr3DAQhUVJaNI0p96LoJdCcCpLsixfCssmbQKBQpL2KsayvNFiS64kF_rvK7Np2IRIhxnQp8e8ee_QgfPOIPShJOeMNeTLVo8lIZRQUb1Bx5TUdUGYZAd7_RE6jXFL8pGS07J-i44Y4xWRFTtG05WBrki-WCpe-3GCYKN32Pf4FibbYXAdXs3Jj5BM7lyyG-PwhUlGJ5vBexNTxL0POD0YfGFh43y0cRG4W93eFWv_q6D42vU7_j067GGI5vSxnqCf3y7v11fFzY_v1-vVTaF5XaVCtLXoQJPO0LZtZFsBMGGkpgyykOkkF02ZLwiiedMySngjJGE9iK42AtgJ-rrTneZ2NJ02LgUY1BTsCOGv8mDV8xdnH9TG_1G1pJLxOgt8fhQI_vecTarRRm2GAZzxc1SU17KSgogF_fQC3fo5uGxPUcFLwvPaSaY-7k_0NMr_MDJwtgN08DEG0z8hJVFL2mov7UyXL2htEywrznbs8Oqff9X7q-8 |
CitedBy_id | crossref_primary_10_5937_jomb0_36107 crossref_primary_10_1002_14651858_CD013705_pub3 crossref_primary_10_1007_s00430_023_00774_9 crossref_primary_10_1128_spectrum_02351_21 crossref_primary_10_1038_s41598_023_31177_8 crossref_primary_10_1016_j_jcv_2021_104938 crossref_primary_10_1007_s11845_021_02863_1 crossref_primary_10_3390_bioengineering10030322 crossref_primary_10_1016_j_jviromet_2021_114299 crossref_primary_10_1002_jmv_26884 crossref_primary_10_1007_s15010_021_01723_5 crossref_primary_10_1016_j_cca_2023_117586 crossref_primary_10_1002_jmv_27094 crossref_primary_10_3390_v13081459 crossref_primary_10_3389_fmed_2022_870738 crossref_primary_10_3390_diagnostics11071290 crossref_primary_10_3390_jcm10173854 crossref_primary_10_3390_diagnostics12020475 crossref_primary_10_3390_v14081653 crossref_primary_10_1016_j_diagmicrobio_2021_115490 crossref_primary_10_1016_j_heliyon_2023_e23518 crossref_primary_10_1016_j_jcv_2021_104909 crossref_primary_10_1016_j_jcvp_2021_100020 crossref_primary_10_1128_Spectrum_00846_21 crossref_primary_10_3390_jcm10112404 crossref_primary_10_1371_journal_pmed_1003735 crossref_primary_10_1016_j_ijid_2021_03_051 crossref_primary_10_1016_j_talanta_2023_124462 crossref_primary_10_1136_bmjebm_2021_111828 crossref_primary_10_1080_23744235_2022_2083226 crossref_primary_10_1515_cclm_2022_0849 crossref_primary_10_1007_s00430_021_00719_0 crossref_primary_10_3390_diagnostics12020447 crossref_primary_10_1371_journal_pone_0266375 crossref_primary_10_1186_s12985_024_02371_5 crossref_primary_10_1016_j_jcv_2023_105419 crossref_primary_10_1515_dx_2022_0067 crossref_primary_10_1002_jmv_27108 crossref_primary_10_3233_HAB_211513 crossref_primary_10_3390_v14040654 crossref_primary_10_1515_cclm_2022_1166 crossref_primary_10_31362_patd_1160801 crossref_primary_10_3390_diagnostics11122217 crossref_primary_10_3390_diagnostics12061302 crossref_primary_10_1016_j_jcv_2021_104994 crossref_primary_10_3390_diagnostics12061388 crossref_primary_10_1002_jmv_27153 crossref_primary_10_1371_journal_pmed_1004011 crossref_primary_10_1038_s41598_021_02197_z crossref_primary_10_1515_cclm_2022_1039 crossref_primary_10_1016_j_eclinm_2021_100954 crossref_primary_10_1016_j_diagmicrobio_2021_115514 crossref_primary_10_1515_cclm_2022_0661 crossref_primary_10_1002_jmv_27679 crossref_primary_10_3390_diagnostics12010110 crossref_primary_10_1515_cclm_2022_0345 crossref_primary_10_3389_fmicb_2021_714242 crossref_primary_10_3390_biomedicines10092327 crossref_primary_10_1093_labmed_lmac089 crossref_primary_10_3390_v13050809 crossref_primary_10_1371_journal_pone_0269329 crossref_primary_10_3233_HAB_200441 crossref_primary_10_3390_diagnostics11112110 crossref_primary_10_3390_jcm10132774 crossref_primary_10_1515_cclm_2021_0455 |
Cites_doi | 10.1016/j.cmi.2020.09.030 10.1007/s10096-020-03913-9 10.1016/j.jcv.2020.104712 10.1016/j.jcv.2020.104612 10.1016/j.jviromet.2020.114024 10.5858/arpa.2020-0443-SA 10.1016/j.ijid.2020.08.029 10.1016/j.jcv.2020.104500 10.1016/j.jcv.2020.104654 10.1016/j.jcv.2020.104455 10.1515/cclm-2020-1413 10.2807/1560-7917.ES.2020.25.32.2001483 10.3390/diagnostics10040202 10.3390/v12121420 10.1515/cclm-2020-1602 10.1016/j.jcv.2020.104684 10.1093/clinchem/hvaa213 10.1515/dx-2020-0154 10.1128/JCM.02589-20 10.1016/j.cmi.2020.09.057 10.1002/14651858.CD013705 10.1101/2020.08.04.20167932 10.1101/2020.10.16.20213850 10.1016/j.bios.2020.112817 10.1007/s15010-020-01542-0 10.1016/j.jcv.2020.104659 |
ContentType | Journal Article |
Copyright | 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 by the authors. 2021 |
Copyright_xml | – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 by the authors. 2021 |
DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.3390/jcm10020265 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) Coronavirus Research Database ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2077-0383 |
ExternalDocumentID | PMC7828347 33450853 10_3390_jcm10020265 |
Genre | Journal Article |
GeographicLocations | Belgium United States--US Switzerland |
GeographicLocations_xml | – name: Switzerland – name: United States--US – name: Belgium |
GroupedDBID | 53G 5VS 7X7 8FI 8FJ AADQD AAFWJ AAYXX ABDBF ABUWG ACUHS ADBBV AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU CITATION DIK FYUFA HMCUK HYE IAO IHR ITC KQ8 M48 MODMG M~E OK1 PGMZT PHGZM PHGZT PIMPY RPM UKHRP GROUPED_DOAJ NPM 3V. 7XB 8FK AZQEC COVID DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c475t-6b76dac0de2bb98b5aa36e8c23afeced84691919a60c49b320496803fa6d7e6a3 |
IEDL.DBID | 7X7 |
ISSN | 2077-0383 |
IngestDate | Thu Aug 21 14:29:30 EDT 2025 Fri Jul 11 05:11:39 EDT 2025 Sun Jun 29 12:34:51 EDT 2025 Thu Jan 02 22:32:37 EST 2025 Tue Jul 01 04:34:24 EDT 2025 Thu Apr 24 23:09:14 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | COVID-19 SARS-CoV-2 antigen testing automated assay manual assay |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c475t-6b76dac0de2bb98b5aa36e8c23afeced84691919a60c49b320496803fa6d7e6a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-7644-5298 0000-0002-4151-9760 |
OpenAccessLink | https://www.proquest.com/docview/2641044210?pq-origsite=%requestingapplication% |
PMID | 33450853 |
PQID | 2641044210 |
PQPubID | 5046890 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7828347 proquest_miscellaneous_2478586067 proquest_journals_2641044210 pubmed_primary_33450853 crossref_primary_10_3390_jcm10020265 crossref_citationtrail_10_3390_jcm10020265 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20210113 |
PublicationDateYYYYMMDD | 2021-01-13 |
PublicationDate_xml | – month: 1 year: 2021 text: 20210113 day: 13 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Journal of clinical medicine |
PublicationTitleAlternate | J Clin Med |
PublicationYear | 2021 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Andreani (ref_27) 2020; 39 Singanayagam (ref_28) 2020; 25 ref_12 Kruttgen (ref_13) 2020; 288 ref_11 ref_10 ref_31 Liu (ref_16) 2020; 173 ref_18 Linares (ref_14) 2020; 133 ref_15 Mak (ref_17) 2020; 133 Mak (ref_22) 2021; 134 Bohn (ref_5) 2020; 58 ref_25 ref_24 ref_23 ref_20 ref_1 ref_3 Scohy (ref_19) 2020; 129 ref_2 Ogawa (ref_30) 2020; 131 Hirotsu (ref_29) 2020; 99 Mak (ref_21) 2020; 129 ref_26 ref_8 ref_4 ref_7 ref_6 Cerutti (ref_9) 2020; 132 33939481 - Ann Intern Med. 2021 May;174(5):JC56 |
References_xml | – ident: ref_7 – ident: ref_15 doi: 10.1016/j.cmi.2020.09.030 – volume: 39 start-page: 1059 year: 2020 ident: ref_27 article-title: Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards publication-title: Eur. J. Clin. Microbiol. Infect. Dis. doi: 10.1007/s10096-020-03913-9 – ident: ref_24 – volume: 134 start-page: 104712 year: 2021 ident: ref_22 article-title: Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS-CoV-2 publication-title: J. Clin. Virol. doi: 10.1016/j.jcv.2020.104712 – volume: 131 start-page: 104612 year: 2020 ident: ref_30 article-title: Another false-positive problem for a SARS-CoV-2 antigen test in Japan publication-title: J. Clin. Virol. doi: 10.1016/j.jcv.2020.104612 – volume: 288 start-page: 114024 year: 2020 ident: ref_13 article-title: Comparison of the SARS-CoV-2 Rapid Antigen Test to the Real Star Sars-CoV-2 RT PCR Kit publication-title: J. Virol. Methods doi: 10.1016/j.jviromet.2020.114024 – ident: ref_31 doi: 10.5858/arpa.2020-0443-SA – volume: 99 start-page: 397 year: 2020 ident: ref_29 article-title: Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients publication-title: Int. J. Infect. Dis. doi: 10.1016/j.ijid.2020.08.029 – volume: 129 start-page: 104500 year: 2020 ident: ref_21 article-title: Evaluation of rapid antigen test for detection of SARS-CoV-2 virus publication-title: J. Clin. Virol. doi: 10.1016/j.jcv.2020.104500 – volume: 132 start-page: 104654 year: 2020 ident: ref_9 article-title: Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2 publication-title: J. Clin. Virol. doi: 10.1016/j.jcv.2020.104654 – volume: 129 start-page: 104455 year: 2020 ident: ref_19 article-title: Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis publication-title: J. Clin. Virol. doi: 10.1016/j.jcv.2020.104455 – volume: 58 start-page: 2001 year: 2020 ident: ref_5 article-title: IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2 publication-title: Clin. Chem. Lab. Med. doi: 10.1515/cclm-2020-1413 – volume: 25 start-page: 2001483 year: 2020 ident: ref_28 article-title: Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 publication-title: Eurosurveillance doi: 10.2807/1560-7917.ES.2020.25.32.2001483 – ident: ref_1 doi: 10.3390/diagnostics10040202 – ident: ref_20 doi: 10.3390/v12121420 – ident: ref_6 – ident: ref_25 – ident: ref_2 doi: 10.1515/cclm-2020-1602 – ident: ref_4 – volume: 133 start-page: 104684 year: 2020 ident: ref_17 article-title: Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus publication-title: J. Clin. Virol. doi: 10.1016/j.jcv.2020.104684 – ident: ref_18 doi: 10.1093/clinchem/hvaa213 – ident: ref_23 doi: 10.1515/dx-2020-0154 – ident: ref_12 doi: 10.1128/JCM.02589-20 – ident: ref_10 doi: 10.1016/j.cmi.2020.09.057 – ident: ref_11 doi: 10.1002/14651858.CD013705 – ident: ref_26 doi: 10.1101/2020.08.04.20167932 – ident: ref_8 doi: 10.1101/2020.10.16.20213850 – volume: 173 start-page: 112817 year: 2020 ident: ref_16 article-title: Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen publication-title: Biosens. Bioelectron. doi: 10.1016/j.bios.2020.112817 – ident: ref_3 doi: 10.1007/s15010-020-01542-0 – volume: 133 start-page: 104659 year: 2020 ident: ref_14 article-title: Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms publication-title: J. Clin. Virol. doi: 10.1016/j.jcv.2020.104659 – reference: 33939481 - Ann Intern Med. 2021 May;174(5):JC56 |
SSID | ssj0000884217 |
Score | 2.43974 |
Snippet | (1) Background: The detection of SARS-CoV-2 RNA in nasopharyngeal samples through real-time reverse transcription-polymerase chain reaction (RT-PCR) is... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 265 |
SubjectTerms | Antigens Asymptomatic Automation Clinical medicine Coronaviruses COVID-19 Laboratories Patients Reading Severe acute respiratory syndrome coronavirus 2 Software |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1RT9swED4xkKa9TBtsIxsgT-IJyVsaO7bzgFBVhrpJ3QPQibfIjh1RxJyOptL27zknaUQZ4imRfEms--z4--TzHcDhoIiZ1KWjqdWKov5KqNHcUSm4STQvjWjSF09-ivGU_7hKrzZgVYyzc-DiSWkX6klN726__P3z7wQn_HFQnCjZv94Uv0MiUVQT6QvYwiVJhhk66Xh-80tWiiP3bs_nPX5mfUX6j2Y-jpZ8sPycvYHXHW8kwxbot7Dh_Da8nHQ74zswHyNYtK5ouJJRX12QVCU51_OZJdpbMlzWFVJUh3e-Dnk4yamrm2AsTy6xOwuCHJYgJySnbQjebBFecDE8v6Cj6hdNyPcueMu_g-nZt8vRmHbVFGjBZVpTYaSwuoitS4zJlEm1ZsKpImEIVeEsEpEMxVumRVzwzLAEtYNQMSu1sNIJzd7Dpq-82wWCEiV2IWuMVWk4Fa1dZjJEnA9Ky7TTERytPJoXXarxUPHiNkfJEdyfP3B_BIe98bzNsPG02d4Kmnw1SnJkcygnEdo4gs99M06QsOuhvauWaMOlShXqNBnBhxbJ_juMcSSoKYtArmHcG4Tk2-stfnbdJOFGZqUYlx-f79YneJWEIJh4QAdsDzbru6XbRxZTm4NmhN4DC5ryEw priority: 102 providerName: Scholars Portal |
Title | Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33450853 https://www.proquest.com/docview/2641044210 https://www.proquest.com/docview/2478586067 https://pubmed.ncbi.nlm.nih.gov/PMC7828347 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFD6CTUK8IO6EXWSkPSFZS2PHdp6m0m0qSJ1Qt6G-RXbsiCJwCk3_P8eJm62AeEoiO4nl48v32cffATgZVSmTunY0t1pR5F8ZNZo7KgU3mea1EZ188exKTG_5p0W-iAtu6-hWuR0Tu4HaNlVYIz_FiRuZA0eGcrb6SUPUqLC7GkNoPIT9IF0WXLrkQg5rLNiD8AXZH8tjyO5Pv1U_guYoEo98dyL6C13-6SR5b9a5fApPIlwk496-z-CB88_h0SxuiL-A1RRtRNuGhiuZDEEFSVOTuV4tLdHekvGmbRCZOrzzbZDfJOeu7XywPLnB4qwJQleCUJCc9553y3X4wPV4fk0nzReakY_RZ8u_hNvLi5vJlMYgCrTiMm-pMFJYXaXWZcYUyuRaM-FUlTG0UOUs4o8COVuhRVrxwrAMKYNQKau1sNIJzV7Bnm-8ewMEmUnqgliMVXk4DK1dYQo0NB_VlmmnE3i_rdGyigrjIdDF9xKZRqj-8l71J3AyZF71whr_zna4NU0Ze9e6vGsLCbwbkrFfhM0O7V2zwTxcqlwhPZMJvO4tOfyHMY64NGcJyB0bDxmC5vZuil9-7bS3EVApxuXb_xfrAB5nwfclHdERO4S99tfGHSF4ac1x10KPYf_DxdXnOT7NuPoNtHnyUw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeEN9kG2Ck8YJkLY0dO3lAqLSbWrZWqOvQ3jI7dkQRS8qaCvFP8Tdybj5YAfG2p0TKyTnZZ9_vZ5_vAPa7qc-kyiwNjYoo8q-AasUtlYLrQPFMi3X64vFEDM_4h_PwfAt-NndhXFhlsyauF2pTpG6P_AAdNzIHjgzl3eIbdVWj3OlqU0KjMotj--M7Urbl29EAx_d1EBwdzvpDWlcVoCmXYUmFlsKo1Dc20DqOdKgUEzZKA4Yqp9agQ46RxMRK-CmPNQsQQ4vIZ5kSRlqhGLZ7C7Y5QyrTge33h5OP03ZXB-csqiiri4CMxf7Bl_TSZTlFqhNuur6_8OyfYZnX_NzRfbhXA1TSqyzqAWzZ_CHcHtdH8I9gMUSroGVB3ZP02zKGpMjIVC3mhqjckN6qLBALW3zLS5fwkwxsuY76yskM1VkSBMsEwScZVLF-86Vr4LQ3PaX94hMNyKiOEssfw9mNdPAT6ORFbp8BQS7kW5eexkShu36tbKxjNC3ezQxTVnnwpunRJK1zmrvSGl8T5Dau-5Nr3e_Bfiu8qFJ5_FtsrxmapJ7Py-S39Xnwqv2MM9Edr6jcFiuU4TIKIySE0oOn1Ui2_2GMIxIOmQdyY4xbAZfle_NLPv-8zvaNEC5iXO78X62XcGc4G58kJ6PJ8S7cDVzkjd-lXbYHnfJqZZ8jdCr1i9peCVzc9BT5BZNWLyc |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcEO-mFDBSuSBZTWLHTg4VWu2y2qW0Qn2gvQU7dsQimmy7WVX8NX4d47zoAuLWUyJl5Fj2jP2NPfMNwF6Q-Uyq3NLIqJii_xVSrbilUnAdKp5rUdMXHx2LyTn_MItmG_Czy4VxYZXdmlgv1KbM3Bn5Pm7c6Dlwl3GSt2ERn0bjd4tL6ipIuZvWrpxGoyKH9sc1um_Lg-kI5_pNGI7fnw0ntK0wQDMuo4oKLYVRmW9sqHUS60gpJmychQy7n1mDm3OCDk2ihJ_xRLMQ8bSIfZYrYaQVimG7d-CuZFHgbEzOZH--g9aLnZVNSiBjib__LbtwfKfo9ETrm-BfyPbPAM0bO974AdxvoSoZNLr1EDZs8Qi2jtrL-MewmKB-0Kqk7kmGfUFDUubkRC3mhqjCkMGqKhEVW3wrKkf9SUa2quO_CnKG3VkShM0EYSgZNVF_86Vr4HRwckqH5WcakmkbL1Y8gfNbGd6nsFmUhd0Ggl6Rbx1RjYkjl4itbKITVDIe5IYpqzx4241omrXs5q7IxvcUvRw3_OmN4fdgrxdeNKQe_xbb7aYmbS17mf7WQw9e95_RJt1FiypsuUIZLuMoRtdQevCsmcn-P4xxxMQR80CuzXEv4Pi-178U86817zeCuZhxufP_br2CLTSM9OP0-PA53AtdCI4f0IDtwmZ1tbIvEENV-mWtrAS-3LZ1_AI6kTH3 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Head-to-Head+Comparison+of+Rapid+and+Automated+Antigen+Detection+Tests+for+the+Diagnosis+of+SARS-CoV-2+Infection&rft.jtitle=Journal+of+clinical+medicine&rft.au=Favresse%2C+Julien&rft.au=Gillot%2C+Constant&rft.au=Oliveira%2C+Maxime&rft.au=Cadrobbi%2C+Julie&rft.date=2021-01-13&rft.pub=MDPI+AG&rft.eissn=2077-0383&rft.volume=10&rft.issue=2&rft.spage=265&rft_id=info:doi/10.3390%2Fjcm10020265&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2077-0383&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2077-0383&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2077-0383&client=summon |